Can-Fite BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 66.9%.

Top 18 shareholders own 5.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.31%	Armistice Capital LLC	67,608,900	₪1.9m	-56.8%	0.01%
1%	Morgan Stanley, Investment Banking and Brokerage Investments	20,342,100	₪569.6k	21.5%	no data
0.23%	Rhumbline Advisers Ltd Partnership	4,619,400	₪129.3k	-16.7%	no data
0.16%	Hudson River Trading LLC, Asset Management Arm	3,237,000	₪90.6k	0%	no data
0.15%	Virtu Financial LLC, Asset Management Arm	3,125,100	₪87.5k	0%	no data
0.063%	Alfi Benedek Investment Management Ltd.	1,293,203	₪36.2k	18.4%	0.09%
0.045%	I.B.I Mutual Funds Management (1978) Ltd.	910,774	₪25.5k	0%	no data
0.044%	ClearArc Capital, Inc.	900,000	₪25.2k	0%	no data
0.013%	Pnina Fishman	263,433	₪7.4k	0%	no data
0.0088%	National Bank Investments Inc.	180,000	₪5.0k	0%	no data
0.0081%	Citigroup Inc.,Banking and Securities Investments	165,900	₪4.6k	0%	no data
0.0065%	Ilan Cohn	133,567	₪3.7k	0%	no data
0.0029%	Activest Wealth Management, LLC	60,000	₪1.7k	0%	no data
0.0027%	Advisor Group Holdings, Inc., Asset Management Arm	55,500	₪1.6k	0%	no data
0.0015%	Avion Wealth, LLC	30,000	₪841.3	0%	no data
0.0012%	Guy Regev	24,240	₪681.1	0%	no data
0.00029%	Toronto-Dominion Bank, Banking Investments	6,000	₪166.0	0%	no data
0.00006%	Motti Farbstein	1,133	₪34.3	0%	no data